Aton (EPA:ALTAO)

Market Cap	6.08M
Revenue (ttm)	614.00K
Net Income (ttm)	-1.10M
Shares Out	800.07M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	883,460
Average Volume	556,183
Open	0.0076
Previous Close	0.0074
Day's Range	0.0074 - 0.0078
52-Week Range	0.0060 - 0.0159
Beta	0.27
RSI	48.61
Earnings Date	Oct 30, 2025

About Aton

Aton operates as a bioscience company in France. It engages in drug development preclinical and clinical services, production of monoclonal antibodies, laboratory equipment production, and designing and manufacturing of medical devices, as well as provision of human tissues. The company was founded in 1998 and is headquartered in Strasbourg, France.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALTAO

Financial Performance

In 2024, Aton's revenue was 614,000, an increase of 0.33% compared to the previous year's 612,000. Losses were -1.10 million, -86.01% less than in 2023.